Atlas Trials

Rituximab to Prevent Recurrence of Proteinuria

Clinical trial NCT01164098 · TERMINATED

Trial details

NCT number
NCT01164098
Sponsor
George W. Burke
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
FSGSProteinuria
Start date
2012-02-01
Primary completion
2016-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.